FDA Guidance Documents·· 原文未提供具体时分
Review Criteria for Assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive Protein (hsCRP) and Cardiac C-Reactive Assays: Guidance for Industry and FDA Staff
Review Criteria for Assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive Protein (hsCRP) and Cardiac C-Reactive Assays: Guidance for Industry and FDA Staff
AI 导读
FDA 官方历史目录记录；Final guidance；发布日期：2005-09-22。官方主题：Postmarket, Cardiovascular。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov